نتایج جستجو برای: intravenous iron

تعداد نتایج: 218815  

Journal: :Transfusion Alternatives in Transfusion Medicine 1999

Journal: :Journal of clinical pharmacy and therapeutics 1998
S Bhandari A Brownjohn J Turney

INTRODUCTION Iron replacement therapy reduces the demand for erythropoietin (EPO) in some dialysis patients. It has been postulated that iron supply to the bone marrow is a rate-limiting step in the process of erythropoiesis under erythropoietin stimulation. METHODS We evaluated the economic benefit of intravenous iron therapy for this purpose in a prospective, non-blinded study of 22 haemodi...

Journal: :American Journal of Hematology 2011

Journal: :Molecular Aspects of Medicine 2020

2012
Alhossain A Khalafallah Amanda E Dennis Kath Ogden Iain Robertson Ruth H Charlton Jackie M Bellette Jessica L Shady Nep Blesingk Madeleine Ball

BACKGROUND To date, there are no data available concerning the impact of iron therapy on the long-term well-being and health-related quality of life (HRQoL) in pregnancy. OBJECTIVE To assess the long-term effect of iron therapy on HRQoL in pregnancy. DESIGN This is a follow-up study conducted between January 2010 and January 2011 of an earlier randomised open-label clinical trial of intrave...

ژورنال: دانشور پزشکی 2009
افشار, دکتر رضا , ثانوی, دکتر سوزان , طالقانی‌دوزدوزانی, دکتر حسن , قاسمی, دکتر حسن ,

  Background and Objective: Anemia is one of the major disabling consequences in chronic kidney (CKD) disease which has different etiologies .Inadequate production of Erythropoietin (EPO) is the main cause of anemia. Iron shortage is the other important cause. The aim of this study is to evaluate Anemia Prevalence and iron storage in CKD patients in pre-dialysis and hemodialysis stages.   Mater...

2016
Irwin Gross Shannon Farmer Axel Hofmann Sherri Ozawa Aryeh Shander Matti Aapro

TO THE EDITOR: In the study by Leyland-Jones et al, we question whether the protocol resulted in adequate iron supplementation in both the epoetin alfa (EPO) group and the best standard of care (BSC) group, but especially in the group that was randomly assigned to receive EPO 40,000 IU once per week. The study design recognized that the availability of iron is a limiting factor in the response ...

Journal: :مجله دانشگاه علوم پزشکی شهید صدوقی یزد 0
محمد رحیمیان m rahimian . non علی اصغر شجاعی aa shojaie

introduction: hemodialysis patients often develop resistance to recombinant human erythropoietin due to functional iron deficiency. in these patients iron therapy can be hazardous leading to hemosiderosis. recent studies have suggested that intravenous ascorbic acid may be able to improve this hyporeponsiveness. the aim of this study was to evaluate the effect of intravenous ascorbic acid on fu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید